| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |